In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases
暂无分享,去创建一个
Robert Adamu Shey | S. Ghogomu | K. Esoh | Neba Derrick Nebangwa | C. M. Shintouo | Nkemngo Francis Nongley | B. F. Asa | Ferdinand Njume Ngale | L. Vanhamme | J. Souopgui | Luc Vanhamme | Stephen Mbigha Ghogomu | Kevin Kum Esoh | Cabirou Mounchili Shintouo | Bertha Fru Asa | Jacob Souopgui | Robert Adamu Shey | Stephen Mbigha Ghogomu | Kevin Kum Esoh | Neba Derrick Nebangwa | Cabirou Mounchili Shintouo | Nkemngo Francis Nongley | Bertha Fru Asa | Ferdinand Njume Ngale | Luc Vanhamme | Jacob Souopgui | R. A. Shey
[1] Teruyuki Nagamune,et al. Design of the linkers which effectively separate domains of a bifunctional fusion protein. , 2001, Protein engineering.
[2] Steven A. Williams,et al. Immunisation with a Multivalent, Subunit Vaccine Reduces Patent Infection in a Natural Bovine Model of Onchocerciasis during Intense Field Exposure , 2009, PLoS neglected tropical diseases.
[3] D. Pritchard,et al. Vaccination against gastrointestinal nematodes of sheep using purified secretory acetylcholinesterase from Trichostrongylus colubriformis– an initial pilot study , 1994, Parasite immunology.
[4] Ian W. Davis,et al. Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.
[5] R. Gazzinelli,et al. High-Throughput Analysis of Synthetic Peptides for the Immunodiagnosis of Canine Visceral Leishmaniasis , 2011, PLoS neglected tropical diseases.
[6] D. Marciani. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. , 2003, Drug discovery today.
[7] M. Basáñez,et al. Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] E. Pearlman,et al. Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): a novel role for TLR4 and endosymbiotic Wolbachia bacteria , 2003 .
[9] Bo Yao,et al. SVMTriP: A Method to Predict Antigenic Epitopes Using Support Vector Machine to Integrate Tri-Peptide Similarity and Propensity , 2012, PloS one.
[10] P. Hotez,et al. Onchocerca volvulus: The Road from Basic Biology to a Vaccine. , 2018, Trends in parasitology.
[11] M. Basáñez,et al. From river blindness control to elimination: bridge over troubled water , 2018, Infectious Diseases of Poverty.
[12] Rachel Chen. Bacterial expression systems for recombinant protein production: E. coli and beyond. , 2012, Biotechnology advances.
[13] Vasant G Honavar,et al. Predicting linear B‐cell epitopes using string kernels , 2008, Journal of molecular recognition : JMR.
[14] E. Ottesen,et al. Towards a vaccine for onchocerciasis. , 2001, Trends in parasitology.
[15] Navid Nezafat,et al. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches , 2016, Comput. Biol. Chem..
[16] A. Hoerauf,et al. The Major Surface Protein of Wolbachia Endosymbionts in Filarial Nematodes Elicits Immune Responses through TLR2 and TLR41 , 2004, The Journal of Immunology.
[17] K Fukaya,et al. [Rabies virus]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.
[18] Carlos Angulo,et al. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[19] P. Enyong,et al. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. K. Nelson,et al. Immune responses to third stage larvae of Onchocerca volvulus in interferon‐gamma and interleukin‐4 knockout mice , 1998, Parasite immunology.
[21] L. Konaté,et al. Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal , 2009, PLoS neglected tropical diseases.
[22] J. McCarter,et al. Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis , 2007, PLoS neglected tropical diseases.
[23] Irini A. Doytchinova,et al. AllergenFP: allergenicity prediction by descriptor fingerprints , 2014, Bioinform..
[24] Pierre Baldi,et al. High-throughput prediction of protein antigenicity using protein microarray data , 2010, Bioinform..
[25] S. J. Sucheck,et al. Recent Advances in Subunit Vaccine Carriers , 2016, Vaccines.
[26] H. Rotman,et al. Structural and molecular specificity of antibody responses in mice immune to third stage larvae of Onchocerca volvulus , 1996, Parasite immunology.
[27] O. Kale. Onchocerciasis: the burden of disease , 1998 .
[28] M. Boussinesq,et al. Excess mortality associated with blindness in the onchocerciasis focus of the Mbam Valley, Cameroon , 2002, Annals of tropical medicine and parasitology.
[29] L. Kelly-Hope,et al. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis , 2017, Parasites & Vectors.
[30] P. Enyong,et al. Differential Cytokine and Antibody Responses to Adult and Larval Stages of Onchocerca volvulus Consistent with the Development of Concomitant Immunity , 2002, Infection and Immunity.
[31] M. Little,et al. Density-Dependent Mortality of the Human Host in Onchocerciasis: Relationships between Microfilarial Load and Excess Mortality , 2012, PLoS neglected tropical diseases.
[32] C. Dreweck,et al. Ivermectin‐facilitated immunity in onchocerciasis; activation of parasite‐specific Th1‐type responses with subclinical Onchocerca volvulus infection , 1994 .
[33] Navid Nezafat,et al. Production of a novel multi-epitope peptide vaccine for cancer immunotherapy in TC-1 tumor-bearing mice. , 2015, Biologicals : journal of the International Association of Biological Standardization.
[34] S. Lustigman,et al. Towards a recombinant antigen vaccine against Onchocerca volvulus. , 2002, Trends in parasitology.
[35] Steven Reed,et al. Vaccines to combat the neglected tropical diseases , 2011, Immunological reviews.
[36] Robert M. Anthony,et al. Protective immune mechanisms in helminth infection , 2007, Nature Reviews Immunology.
[37] P. Enyong,et al. Immunity to Onchocerciasis: Cells from Putatively Immune Individuals Produce Enhanced Levels of Interleukin-5, Gamma Interferon, and Granulocyte-Macrophage Colony-Stimulating Factor in Response to Onchocerca volvulus Larval and Male Worm Antigens , 2000, Infection and Immunity.
[38] E. Pearce,et al. Th1 and Th2 Cells Help CD8 T-Cell Responses , 2007, Infection and Immunity.
[39] D. Jackson,et al. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice. , 2000, Vaccine.
[40] S. Geiger,et al. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection , 1997, Immunology.
[41] Andrey V Kajava,et al. Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens. , 2007, Endocrine, metabolic & immune disorders drug targets.
[42] N. Brattig,et al. Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density. , 2002, The Journal of infectious diseases.
[43] S. Lustigman,et al. Protective Immunity to the Larval Stages of Onchocerca volvulus Is Dependent on Toll-Like Receptor 4 , 2005, Infection and Immunity.
[44] Massimo Bernaschi,et al. Computational Immunology Meets Bioinformatics: The Use of Prediction Tools for Molecular Binding in the Simulation of the Immune System , 2010, PloS one.
[45] A. Hoerauf,et al. Involvement of Toll-like receptor 4 in the embryogenesis of the rodent filaria Litomosoides sigmodontis , 2003, Medical Microbiology and Immunology.
[46] R. Jenkins,et al. Protective immunity induced by vaccination with Onchocerca volvulus tropomyosin in rodents , 1996, Parasite immunology.
[47] A. D. De Groot,et al. Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases , 2014, Expert review of vaccines.
[48] S. Lustigman,et al. CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions. , 2003, International journal for parasitology.
[49] Jie Liang,et al. CASTp: Computed Atlas of Surface Topography of proteins , 2003, Nucleic Acids Res..
[50] D. Zawieja,et al. Lymphatic Filariasis: Perspectives on Lymphatic Remodeling and Contractile Dysfunction in Filarial Disease Pathogenesis , 2013, Microcirculation.
[51] J. Thornton,et al. Continuous and discontinuous protein antigenic determinants , 1986, Nature.
[52] Morten Nielsen,et al. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction , 2009, BMC Bioinformatics.
[53] Yang Zhang,et al. Scoring function for automated assessment of protein structure template quality , 2004, Proteins.
[54] Darren R. Flower,et al. AllerTOP v.2—a server for in silico prediction of allergens , 2014, Journal of Molecular Modeling.
[55] Leonard Moise,et al. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines , 2015, Human vaccines & immunotherapeutics.
[56] T. Nutman,et al. Diminished Expression and Function of TLR in Lymphatic Filariasis: A Novel Mechanism of Immune Dysregulation , 2005, The Journal of Immunology.
[57] Dmitrij Frishman,et al. PROSO II – a new method for protein solubility prediction , 2012, The FEBS journal.
[58] P. Hotez,et al. New vaccines for neglected parasitic diseases and dengue. , 2013, Translational research : the journal of laboratory and clinical medicine.
[59] Arlo Z. Randall,et al. Stage-Specific Transcriptome and Proteome Analyses of the Filarial Parasite Onchocerca volvulus and Its Wolbachia Endosymbiont , 2016, mBio.
[60] J. Xiang,et al. CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes , 2007, Immunology.
[61] G. Nelson,et al. Immunity to Onchocerca lienalis microfilariae in mice , 1985, Journal of Helminthology.
[62] Manfred J. Sippl,et al. Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..
[63] Jian Peng,et al. Protein Secondary Structure Prediction Using Deep Convolutional Neural Fields , 2015, Scientific Reports.
[64] F. Cho-Ngwa,et al. The Onchocerca volvulus Cysteine Proteinase Inhibitor, Ov-CPI-2, Is a Target of Protective Antibody Response That Increases with Age , 2010, PLoS neglected tropical diseases.
[65] Ishtiaque Ahammad,et al. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach , 2020, International Journal of Biological Macromolecules.
[66] A. Oksanen,et al. Filarioid nematodes in cattle, sheep and horses in Finland , 2008, Acta veterinaria Scandinavica.
[67] E. Pearlman,et al. Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): a novel role for TLR4 and endosymbiotic Wolbachia bacteria. , 2003, Journal of endotoxin research.
[68] Young Eun Kim,et al. Control, Elimination, and Eradication of River Blindness: Scenarios, Timelines, and Ivermectin Treatment Needs in Africa , 2015, PLoS neglected tropical diseases.
[69] M. Taylor,et al. Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice , 1997, Infection and immunity.
[70] T. Nutman,et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. , 1995, The Journal of infectious diseases.
[71] P. Scott,et al. IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. , 1994, Journal of immunology.
[72] Yang Zhang,et al. Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. , 2011, Biophysical journal.
[73] G C P van Zundert,et al. The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.
[74] L. Konaté,et al. Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and Senegal , 2012, PLoS neglected tropical diseases.
[75] R D Appel,et al. Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.
[76] Wei Li,et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes , 2008, BMC Bioinformatics.
[77] X. Mao,et al. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. , 2009, Vaccine.
[78] W. Harnett,et al. Successful vaccination against Onchocerca ochengi infestation in cattle using live Onchocerca volvulus infective larvae , 2007, Parasite immunology.
[79] S. Brunak,et al. SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.
[80] M. Taylor,et al. Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis , 1995, Infection and immunity.
[81] C. Mackenzie,et al. Elimination of onchocerciasis from Africa: possible? , 2012, Trends in parasitology.
[82] Chaok Seok,et al. GalaxyRefine: protein structure refinement driven by side-chain repacking , 2013, Nucleic Acids Res..
[83] R. Lucius,et al. Immunity to Onchocerca spp. in animal hosts. , 2002, Trends in parasitology.
[84] Wei Tian,et al. CASTp 3.0: computed atlas of surface topography of proteins , 2018, Nucleic Acids Res..
[85] Lifang Zhang. Multi-epitope vaccines: a promising strategy against tumors and viral infections , 2017, Cellular & Molecular Immunology.
[86] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[87] A. Mishra,et al. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection , 2017, Scientific Reports.
[88] G. Weil,et al. Diagnostic Tools for Onchocerciasis Elimination Programs. , 2015, Trends in parasitology.
[89] Bjoern Peters,et al. Identifying MHC Class I Epitopes by Predicting the TAP Transport Efficiency of Epitope Precursors , 2003, The Journal of Immunology.
[90] P. Nde,et al. Cell‐Mediated and Monoclonal Antibody‐Dependent Killing of Onchocerca volvulus Microfilariae * , 1992, Scandinavian journal of immunology. Supplement.
[91] S. Sayed,et al. Exploring Lassa Virus Proteome to Design a Multi-epitope Vaccine Through Immunoinformatics and Immune Simulation Analyses , 2020, International Journal of Peptide Research and Therapeutics.
[92] S. P. Akpabio. World Health Organisation , 1983, British Dental Journal.
[93] R. Bethunaickan,et al. TLR Specific Immune Responses against Helminth Infections , 2017, Journal of parasitology research.
[94] Garima Singh,et al. A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria , 2020, International Journal of Biological Macromolecules.
[95] A Ikai,et al. Thermostability and aliphatic index of globular proteins. , 1980, Journal of biochemistry.
[96] Ole Winther,et al. DeepLoc: prediction of protein subcellular localization using deep learning , 2017, Bioinform..
[97] Sachin Kumar,et al. Synonymous codon usage pattern in glycoprotein gene of rabies virus. , 2016, Gene.
[98] P. Hotez,et al. Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. , 2014, International journal for parasitology.
[99] V. Prajapati,et al. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach , 2017, Scientific Reports.
[100] Dmitri I. Svergun,et al. WeNMR: Structural Biology on the Grid , 2011, Journal of Grid Computing.
[101] G. Abbas,et al. Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics , 2020, European Journal of Pharmaceutical Sciences.
[102] A. E. Bianco,et al. Roles for both CD+ and CD8+ T cells in protective immunity against Onchocerca lienalis microfilariae in the mouse , 1995, Parasite immunology.
[103] P. Hotez,et al. The Onchocerciasis Vaccine for Africa—TOVA—Initiative , 2015, PLoS Neglected Tropical Diseases.
[104] P. Hotez,et al. Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies , 2016, PLoS neglected tropical diseases.
[105] Dieter Jahn,et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host , 2005, Nucleic Acids Res..
[106] A. Sette,et al. The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. , 1998, Human immunology.
[107] James J. Lee,et al. Immunoglobulin E and Eosinophil-Dependent Protective Immunity to Larval Onchocerca volvulus in Mice Immunized with Irradiated Larvae , 2004, Infection and Immunity.
[108] S. Babayan,et al. Future prospects and challenges of vaccines against filariasis , 2012, Parasite immunology.
[109] A. Lujan,et al. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. , 1988, The Journal of infectious diseases.
[110] Henrik Nielsen,et al. Predicting Secretory Proteins with SignalP. , 2017, Methods in molecular biology.
[111] O. Kale,et al. Onchocerciasis: the burden of disease. , 1998, Annals of tropical medicine and parasitology.
[112] B. Gerstman,et al. In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever , 2020, Scientific Reports.
[113] L. H. Carvalho,et al. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages , 2002, Nature Medicine.
[114] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[115] J. Kamgno,et al. Important progress towards elimination of onchocerciasis in the West Region of Cameroon , 2017, Parasites & Vectors.
[116] Maria P Rebollo,et al. Onchocerciasis: shifting the target from control to elimination requires a new first-step—elimination mapping , 2018, International health.
[117] B. Boatin. The Onchocerciasis Control Programme in West Africa (OCP) , 2008, Annals of tropical medicine and parasitology.
[118] Irini A. Doytchinova,et al. BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .
[119] Alexandre M. J. J. Bonvin,et al. PRODIGY: a web server for predicting the binding affinity of protein-protein complexes , 2016, Bioinform..
[120] N. Petrovsky,et al. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice , 2016, PLoS neglected tropical diseases.
[121] Germán L. Rosano,et al. Recombinant protein expression in Escherichia coli: advances and challenges , 2014, Front. Microbiol..
[122] Alexandre M. J. J. Bonvin,et al. CPORT: A Consensus Interface Predictor and Its Performance in Prediction-Driven Docking with HADDOCK , 2011, PloS one.
[123] Gajendra PS Raghava,et al. Designing of interferon-gamma inducing MHC class-II binders , 2013, Biology Direct.
[124] J. Browne,et al. Onchocerca volvulus: in vitro killing of microfilaria by neutrophils and eosinophils from experimentally infected chimpanzees. , 1991, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[125] Kuldip K. Paliwal,et al. Sixty-five years of the long march in protein secondary structure prediction: the final stretch? , 2016, Briefings Bioinform..
[126] F. Tzelepis,et al. Impaired Innate Immunity in Tlr4 −/− Mice but Preserved CD8+ T Cell Responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-Deficient Mice , 2010, PLoS pathogens.
[127] A. Onapa,et al. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted. , 2014, The American journal of tropical medicine and hygiene.
[128] G. Colombo,et al. Peptides for immunological purposes: design, strategies and applications , 2013, Amino Acids.
[129] N. Twum-Danso. Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future , 2003, Filaria journal.
[130] Bjoern Peters,et al. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes , 2017, Nucleic Acids Res..
[131] M. V. Regenmortel,et al. Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity , 1996 .